glp-1 for diabetes Patients Also Struggle to Access Agonists How GLP-1 medications are transforming
Description
Not even a question
It should be injected under the skin in the thigh, abdomen, or upper arm
As more studies are being published, more evidence points to the medications protective effects against developing any AMD in patients who do not have any AMD at baseline
This practice may increase the risk of medication overdose or underdose
doi: 10.3390/jcm8081109
Thats why the medication forms are receptor agonists
